Literature DB >> 33106284

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide.

Ashifa Trivedi1, Sadhna Sharma2, Ranjith Govindan3.   

Abstract

We describe the case of an 11-year-old male patient who presented with a new onset of rash after a recent introduction of zonisamide. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome) is a very serious but rare adverse effect of anticonvulsants such as carbamazepine and phenytoin; however, the reported incidence on zonisamide is scant. DRESS syndrome is complex in its presentation. This patient presented with rash, fever, lymphadenopathy, severe skin erythema, oedema and reduced Glasgow Coma Scale (GCS). He was successfully treated with pulsed intravenous methylprednisolone and intravenous immunoglobulin. The patient was discharged home well after a 3-week admission. © European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  case reports; clinical pharmacy; drug-related side effects and adverse reactions; neurology; paediatrics

Mesh:

Substances:

Year:  2020        PMID: 33106284      PMCID: PMC9251162          DOI: 10.1136/ejhpharm-2020-002387

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  21 in total

1.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

2.  Intravenous Immunoglobulin May Be Beneficial as an Add-on Therapy in DRESS.

Authors:  Pedro Giavina-Bianchi; Shih-Wen Huang
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

3.  Carbamazepine-induced DRESS syndrome in a child: rapid response to pulsed corticosteroids.

Authors:  Paul Teng; Boon Tan
Journal:  Dermatol Online J       Date:  2013-05-15

4.  DIHS/DRESS with remarkable eosinophilic pneumonia caused by zonisamide.

Authors:  Rintaro Shibuya; Hideaki Tanizaki; Saeko Nakajima; Itsuko Koyanagi; Tatsuki R Kataoka; Yoshiki Miyachi; Kenji Kabashima
Journal:  Acta Derm Venereol       Date:  2015-02       Impact factor: 4.437

5.  DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy.

Authors:  E Piñana; S H Lei; R Merino; M Melgosa; R De La Vega; E Gonzales-Obeso; E Ramírez; A Borobia; A Carcas
Journal:  J Clin Pharm Ther       Date:  2010-06       Impact factor: 2.512

6.  Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients.

Authors:  Sheikh Javeed Sultan; Farah Sameem; Mohd Ashraf
Journal:  Int J Dermatol       Date:  2014-04-16       Impact factor: 2.736

7.  Successful Intravenous Immunoglobulin Treatment in Pediatric Severe DRESS Syndrome.

Authors:  Nufar Marcus; Keren Smuel; Moran Almog; Dario Prais; Rachel Straussberg; Daniel Landau; Oded Scheuerman
Journal:  J Allergy Clin Immunol Pract       Date:  2017-12-01

Review 8.  Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?

Authors:  Sietse Q Nagelkerke; Taco W Kuijpers
Journal:  Front Immunol       Date:  2015-01-21       Impact factor: 7.561

9.  Successful Treatment of Antiepileptic Drug-Induced DRESS Syndrome with Pulse Methylprednisolone.

Authors:  Celebi Kocaoglu; Ceyda Cilasun; Ece Selma Solak; Gulcan S Kurtipek; Sukru Arslan
Journal:  Case Rep Pediatr       Date:  2013-04-18

10.  Fulminant Type 1 Diabetes Mellitus Caused by Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Case Report and Review of the Literature.

Authors:  Bizhen Zhu; Jinzhun Wu; Guobing Chen; Yungang Yang; Cuili Yi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.